Study of ovarian cancer using advanced imaging
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial uses a special imaging technique to study high-grade serous ovarian cancer. It aims to better understand the tumor to improve treatment. If you have advanced ovarian cancer and are scheduled for surgery, you may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18.
- You have been diagnosed with a specific type of advanced ovarian cancer called high-grade serous ovarian cancer (stages IIIB or IIIC).
- You are able to have surgery to remove the tumor, possibly after prior treatment.
- You can attend all study visits and follow procedures.
- You have signed a consent form and are covered by French health insurance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “biomarkers,” meaning measurable signals in blood and tumor tissue, in people with advanced ovarian-type cancers. The goal is to understand these markers and how they relate to the cancer, which may help guide future care.
This study looks at how medical images relate to genetic patterns in high-grade serous ovarian cancer. It may help find better ways to diagnose and treat this specific type of ovarian cancer.
This study uses lab testing to create a “map” of ovarian cancer cells one cell at a time, to better understand the disease. It likely helps researchers learn which cell types are involved, using samples collected around your surgery.
This study is for people with a specific type of ovarian cancer (high-grade serous) who have not yet had surgery. It looks at how the cancer may resist standard chemotherapy and aims to find ways to overcome that resistance.
This study is looking at how ovarian cancer affects the mesentery (the tissue that holds your intestines in place) in women with advanced ovarian cancer. It helps doctors understand the disease better and may lead to improved treatments.
This study looks for cancer DNA in your blood to understand advanced ovarian cancer better. It helps doctors see how the disease changes over time and may improve future treatments.
Hear when a new High Grade Serous Ovarian Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.